3 completed, 2 withdrawn, 1 active not recruiting, 1 terminated. 4 Phase 2, 1 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Active not recruiting 1, Completed 1, Terminated 1, Withdrawn 1 |
| Not applicable | 1 | Withdrawn 1 |
Follow NanoSHIFT LLC: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Investigation of Laser Assisted Drug Delivery of NanoDOX® NanoDOX® Hydrogel, CO2 Ablative Fractional Laser - Wounds and Injury | Phase 2 | Active not recruiting | Massachusetts General Hospital | 10 | 2023-11-29 | 2026-07-20 |
| Safety and Efficacy Study of NTC-510 to Treat Pain Following Dental Surgery of Third Molars NTC-510 capsules, Placebo Capsules, NTC-510A Capsules - Dental Pain | Phase 2 | Terminated | NanoSHIFT LLC | 52 | 2014-06-01 | 2017-06-23 |
| Study of NanoDOX Hydrogel vs Placebo for Dehisced Surgical Wounds NanoDOX 1% doxycycline monohydrate Hydrogel, placebo hydrogel - Dehisced Surgical Wounds | Not applicable | Withdrawn | NanoSHIFT LLC | 2012-05-01 | 2017-03-13 | |
| Open Label Trial of NanoDOX Hydrogel in Orthopedic Trauma Wounds With and Without Vacuum Assisted Closure Therapy NanoDOX Hydrogel, VAC Alone - Orthopedic Trauma Wounds | Phase 2 | Withdrawn | NanoSHIFT LLC | 2012-04-01 | 2017-06-23 | |
| Study to Assess the PK Profile of NanoBUP Capsules Relative to Suboxone Buprenorphine HCl/Naloxone HCl - Healthy | Completed | NanoSHIFT LLC | 12 | 2010-12-01 | 2017-06-23 | |
| A Single-Dose Study of an Investigational Capsule Formulation of 2 mg/0.5 mg Buprenorphine/Naloxone Buprenorphine / Naloxone - Healthy | Completed | NanoSHIFT LLC | 6 | 2009-04-01 | 2017-06-23 | |
| Safety Study of Topical Doxycycline Gel for Adult Diabetic Lower Extremity Ulcers doxycycline, placebo gel - Diabetic Foot Ulcer | Phase 2 | Completed | NanoSHIFT LLC | 15 | 2009-01-01 | 2017-04-07 |
Wounds and Injuries (2) · Acute Pain (1) · Diabetic Foot (1) · Toothache (1) · Ulcer (1)
Buprenorphine, Naloxone Drug Combination (2) · Buprenorphine (1) · Doxycycline (1) · Laser Therapy (1) · Naloxone (1)
United States (7)
John Abernethy, MD (2) · Dieter Manstein, MD, PhD (1) · Mark Leibowitz, MD (1) · Michael Natalino, MD (1) · William L Buchanan, MD,DDS (1)